<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>研发客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-11T07:24:22+08:00</updated>
  <subtitle>《研发客》公众号由上海汐潮信息技术有限公司提供，行业资深中英文独立编辑记者创办。我们观察药物创新生态，报道临床研究与监管科学。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>默沙东的百年抗疫之路带给我们什么启示？| 进博会专题</title>
    <updated>2020-11-10T21:52:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/JakJ4Jcd5bxMykzQJnZkTw</id>
    <link href="https://mp.weixin.qq.com/s/JakJ4Jcd5bxMykzQJnZkTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康宁杰瑞KN026联合KN046临床Ⅰb期研究数据亮相癌症免疫治疗学会年会（SITC 2020）| 新闻稿</title>
    <updated>2020-11-10T21:52:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/2TNhozwdJ0tAYBkpuj0N5g</id>
    <link href="https://mp.weixin.qq.com/s/2TNhozwdJ0tAYBkpuj0N5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物警戒及受试者权益保护国际研讨会暨CIOMS《药物性肝损伤（DILI）国际共识》发布会下周召开！｜新闻稿</title>
    <updated>2020-11-10T21:52:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/_msxQrPJlxk0knNAdHf9Wg</id>
    <link href="https://mp.weixin.qq.com/s/_msxQrPJlxk0knNAdHf9Wg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>20201111 本周职位精选：临床、PV、R&amp;D、CMC、市场 | 招聘</title>
    <updated>2020-11-10T21:52:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/XyS7a4QhiNQyjZ194TDF7w</id>
    <link href="https://mp.weixin.qq.com/s/XyS7a4QhiNQyjZ194TDF7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>协和麒麟丁锎：中日药监加大临床数据互认，惠及全球患者 ｜DRR专题·外企临床研究策略</title>
    <updated>2020-11-09T23:25:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/SthQ4ZeM5rMJYnbpXIQpPA</id>
    <link href="https://mp.weixin.qq.com/s/SthQ4ZeM5rMJYnbpXIQpPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康与国内多家顶级医院签署战略合作框架备忘录 | 新闻稿</title>
    <updated>2020-11-09T23:25:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/ts3bqFOnJleefgSMIxzL3g</id>
    <link href="https://mp.weixin.qq.com/s/ts3bqFOnJleefgSMIxzL3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>天境生物在2020年SITC年会公布其差异化优势的CD47单抗lemzoparlimab的Ⅰ期临床研究结果|新闻稿</title>
    <updated>2020-11-09T23:25:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/DjluhKmDedrfNx0OkykXQQ</id>
    <link href="https://mp.weixin.qq.com/s/DjluhKmDedrfNx0OkykXQQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康全球研发中国中心：战略升级，创新加速 | 进博会专题</title>
    <updated>2020-11-08T20:32:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/dG9-nKAAy85rXBnKoQstLw</id>
    <link href="https://mp.weixin.qq.com/s/dG9-nKAAy85rXBnKoQstLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创响生物完成2100万美元B轮融资   成功融资逾4千万美元 | 新闻稿</title>
    <updated>2020-11-08T20:32:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/ppMB-elFcpdjflcJp5vk8g</id>
    <link href="https://mp.weixin.qq.com/s/ppMB-elFcpdjflcJp5vk8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田寄来“千纸鹤”：中国加入CAR-NK细胞疗法全球版图 | 进博会专题</title>
    <updated>2020-11-08T11:58:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/I3XX9Cb55GhoCR0gVbKd5w</id>
    <link href="https://mp.weixin.qq.com/s/I3XX9Cb55GhoCR0gVbKd5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物创新，合作之选——首届施维雅生物创新研讨会在上海成功举办 | 新闻稿</title>
    <updated>2020-11-08T11:58:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/a5ZC57Dj9DPdZ8D8FTOfAg</id>
    <link href="https://mp.weixin.qq.com/s/a5ZC57Dj9DPdZ8D8FTOfAg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新产品、新模式、新愿景，BMS携全新形象入场 | 进博会专题</title>
    <updated>2020-11-07T07:24:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/MKMjjMTg3o8QjFnPzt3bFQ</id>
    <link href="https://mp.weixin.qq.com/s/MKMjjMTg3o8QjFnPzt3bFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020进博会礼来携手产学研共话全球抗疫 | 新闻稿</title>
    <updated>2020-11-07T07:24:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/MGQ25xU0xuJS7PGrnr7OGw</id>
    <link href="https://mp.weixin.qq.com/s/MGQ25xU0xuJS7PGrnr7OGw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首秀即出彩  再鼎医药进博会期间达成多项重磅合作 | 新闻稿</title>
    <updated>2020-11-07T07:24:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/lmMnsWYU5OvTGNgX-Lt_Yg</id>
    <link href="https://mp.weixin.qq.com/s/lmMnsWYU5OvTGNgX-Lt_Yg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“创新大赛”完美收官，勃林格殷格翰“草根创新”助力中国本土创新｜ 遇见张巍怡</title>
    <updated>2020-11-06T10:39:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/yxOZuEZX3ABAbjTVpLfg8g</id>
    <link href="https://mp.weixin.qq.com/s/yxOZuEZX3ABAbjTVpLfg8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11月份CHIC Showcase #4企业家在线路演</title>
    <updated>2020-11-06T10:39:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/MGZLr5boDpPW1Aam6o1OEA</id>
    <link href="https://mp.weixin.qq.com/s/MGZLr5boDpPW1Aam6o1OEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>特殊的2020年，同心抗疫，创新向前！ | 进博会专题</title>
    <updated>2020-11-04T23:27:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/bKa6P9658IlqXnE1SGVTjA</id>
    <link href="https://mp.weixin.qq.com/s/bKa6P9658IlqXnE1SGVTjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>与其被动不如主动变革，大型公立研究机构如何升级转型｜“GCP平台创新论坛”第一现场</title>
    <updated>2020-11-04T23:27:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/hV011xhLjB323Uw_2-AAfA</id>
    <link href="https://mp.weixin.qq.com/s/hV011xhLjB323Uw_2-AAfA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>实体肿瘤新突破：Selinexor用于脂肪肉瘤Ⅲ期临床研究达到主要终点 | 新闻稿</title>
    <updated>2020-11-04T23:27:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/WM0ZAdTZq7Zj1ALz4MHkSg</id>
    <link href="https://mp.weixin.qq.com/s/WM0ZAdTZq7Zj1ALz4MHkSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>20201105 本周职位精选：亚虹医药、R&amp;D、临床 | 招聘</title>
    <updated>2020-11-04T23:27:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/LQnYykpCPGS8k0DgS-VGFQ</id>
    <link href="https://mp.weixin.qq.com/s/LQnYykpCPGS8k0DgS-VGFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>